Literature DB >> 27867049

Improving Rates of Post-Essure Hysterosalpingography in an Urban Population Using Electronic Tracking Reminders.

Yu-Han Virginia Hu1, Kavita Shah Arora2.   

Abstract

STUDY
OBJECTIVE: To demonstrate the efficacy of electronic reminders for follow-up hysterosalpingography (HSG) after Essure hysteroscopic sterilization in an urban tertiary care hospital obstetrics and gynecology practice.
DESIGN: Retrospective cohort study (Canadian Task Force classification II-3).
SETTING: Obstetrics and gynecology practice at a university-affiliated urban tertiary care teaching hospital. PATIENTS: Two hundred and fifty patients who underwent Essure hysteroscopic sterilization between June 2011 and July 2014. INTERVENTION: Implementation of electronic reminders for the office staff.
MEASUREMENTS AND MAIN RESULTS: Two hundred and fifty of 259 patients (96.5%) underwent Essure hysteroscopic sterilization and successful placement of coils into bilateral Fallopian tubes. Among these 250 patients, 135 (54%) returned for HSG at 3 months post-Essure as advised at the time of procedure. The use of electronic reminders prompted another 45 patients (18%) to return for HSG, improving the total post-Essure follow-up rate to 72%.
CONCLUSION: Electronic reminders for the office staff of an urban tertiary care hospital's obstetrics and gynecology practice is an effective method for improving the rate of post-Essure HSG.
Copyright © 2016 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Electronic medical record

Mesh:

Year:  2016        PMID: 27867049      PMCID: PMC5293601          DOI: 10.1016/j.jmig.2016.10.019

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  9 in total

1.  Hysteroscopic sterilization: 10-year retrospective analysis of worldwide pregnancy reports.

Authors:  M G Munro; J E Nichols; B Levy; M P H Vleugels; S Veersema
Journal:  J Minim Invasive Gynecol       Date:  2013-10-12       Impact factor: 4.137

2.  Improving hysterosalpingogram confirmatory test follow-up after Essure hysteroscopic sterilization.

Authors:  Maryam Guiahi; Kara N Goldman; Margaret M McElhinney; Christopher G Olson
Journal:  Contraception       Date:  2010-03-04       Impact factor: 3.375

3.  Unintended pregnancy in the United States: incidence and disparities, 2006.

Authors:  Lawrence B Finer; Mia R Zolna
Journal:  Contraception       Date:  2011-08-24       Impact factor: 3.375

Review 4.  Pregnancies after hysteroscopic sterilization: a systematic review.

Authors:  Tara P Cleary; Naomi K Tepper; Carrie Cwiak; Maura K Whiteman; Denise J Jamieson; Polly A Marchbanks; Kathryn M Curtis
Journal:  Contraception       Date:  2012-10-04       Impact factor: 3.375

5.  Adherence to hysterosalpingogram appointments following hysteroscopic sterilization among low-income women.

Authors:  Ophra Leyser-Whalen; Abbey B Berenson
Journal:  Contraception       Date:  2013-08-01       Impact factor: 3.375

6.  Improving adherence to hysterosalpingography after hysteroscopic sterilization using an electronic reminder.

Authors:  Semhar Mahmud; Nigel Pereira; Katherine C Taylor; Lamar E Ekbladh
Journal:  J Minim Invasive Gynecol       Date:  2014-10-16       Impact factor: 4.137

7.  Post-Essure hysterosalpingography compliance in a clinic population.

Authors:  Valerie I Shavell; Mazen E Abdallah; Michael P Diamond; David C Kmak; Jay M Berman
Journal:  J Minim Invasive Gynecol       Date:  2008-04-28       Impact factor: 4.137

8.  What are the factors predictive of hysterosalpingogram compliance after female sterilization by the Essure procedure in a publicly insured population?

Authors:  David L Howard; Jeffrey Wall; Julie L Strickland
Journal:  Matern Child Health J       Date:  2013-12

9.  Confirmation Testing of Essure Microinserts in Unintended Pregnancies Using a 10-Year Retrospective Database.

Authors:  Darrien Rattray; Peter Thiel; Ian Suchet; John Thiel
Journal:  J Minim Invasive Gynecol       Date:  2016-05-31       Impact factor: 4.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.